Commonly prescribed psychiatric drugs: do they work?

4932655275_7811863fe8_o

John Baker summarises a review of commonly prescribed medication that covers seven psychiatric drugs, including antidepressants, antipsychotics, benzodiazepines, amphetamines, methylphenidate and cholinesterase inhibitors.

[read the full story...]

Cognitive tests for dementia: MMSE, Mini-Cog and ACE-R

7158418_2215ef4a6e_b

Akshay Nair explores the results of a systematic review of cognitive tests for dementia and mild cognitive impairment, which focuses on the MMSE, Mini-Cog, ACE-R and MoCA instruments. Along the way he explains how diagnostic tests work and how sensitivity and specificity are useful measures to get your head around.

[read the full story...]

Donepezil, nursing home placement and Alzheimer’s Disease

15482576136_fe7b9b5f42_k

Caroline Struthers reports on the findings of a follow-up paper of the DOMINO-AD trial, which compares Donepezil and Memantine for Moderate to Severe Alzheimer’s Disease, and looks at the effects these two drugs have on nursing home placement.

[read the full story...]

Can higher educational attainment help lower dementia risk?

6385852693_6c1a743012_b

Raluca Lucacel summarises a recent meta-analysis of prospective cohort studies, which investigates the dose-response between education and the risk of dementia.

[read the full story...]

Dementia risk factors in people with mild cognitive impairment

People with a learning disability and family carers are able to talk about end-of-life care and healthcare professionals need to acknowledge and respect this expertise

Akshay Nair summarises a recent systematic review and meta-analysis of modifiable predictors of dementia in mild cognitive impairment. The meta-analysis finds that diabetes and the presence of any neuropsychiatric symptoms significantly predicted the conversion of mild cognitive impairment to dementia.

[read the full story...]

Lifestyle changes for cognition and dementia: better than a new drug?

shutterstock_2378100

Should all molecular research institutes looking at neurodegenerative diseases be replaced by parks, playgrounds and cycle paths? Mark Horowitz highlights a recent systematic review of modifiable risk factors associated with cognition and dementia, which suggests that from a public health perspective, there may be some sense in this idea.

[read the full story...]

Risk factors for dementia: separating the facts from the myths

shutterstock_223825078

We are grateful to Josephine Neale who has read the 104 page World Alzheimer Report 2014 and summarised it for us in this very readable blog. The report is a comprehensive analysis of the risk factors for dementia, which focuses on a range of protective and modifiable factors.

[read the full story...]

Cognitive and exercise interventions for older adults with and without cognitive impairment

Jake Crawshaw reports on a recent systematic review of cognitive and exercise interventions for older people with and without cognitive impairment.

[read the full story...]

Alternatives to medication for agitation in dementia

shutterstock_183376727

Andrés Fonseca summarises the findings of a recent systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in dementia.

[read the full story...]